Geisinger Health System's Steele Institute for Health Innovation will use Medial EarlySign's LGI-Flag software to develop artificial intelligence-based technologies to identify patients who are at a high risk of lower gastrointestinal disorders, as well as other chronic and acute diseases. The software will be used to evaluate changes in EHR data and blood test values to flag these patients.
Geisinger, Medial EarlySign to develop AI tech for high-risk patients
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.